By Professor Ric Day

Conference Papers

Day RO, 1999, 'Drug interactions with methadone: Pharmacokinetics', in Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, presented at Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, 28 January 1999 - 29 January 1999

Weekes LM; Brooks C; Day RO, 1998, 'Describing the performance of pharmacy and therapeutics committees', in Clinical Pharmacology and Therapeutics, Mosby, St Louis, MO, USA, pp. 179, presented at Clinical and Pharmacology Therapeutics

Carmody JJ; Walker JS; Sheather-Reid R; Vial JH; Day RO, 1998, 'Non steroidal anti-inflammatory drugs (NSAIDS) in rheumatoid and osteoarthritis: support for the concept of `responders` and `non-responders`', in Naunyn - Schmiedebergs Archives of Pharmacology, Springer, New York, NY, USA, pp. 15, presented at Archives of Pharmacology 358, Munich, Germany

Ziegler JB; Graham GG; Day RO; Williams KM; Milligan MK, 1997, 'THERAPEUTIC CONSIDERATIONS FROM PHARMACOKINETICS AND METABOLISM: IBUPROFEN AND PARACETAMOL.', in Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, presented at Safety and Efficacy of non-prescription analgesics and NSAIDS, San Francisco, California USA, 17 March 1997 -

Conference Posters

Chroinin DN; Xiao D; Sandhu A; Brazel C; Farnham N; Neto HM; Perram J; Roach TS; Sutherland E; Day R; Beveridge A, 2015, 'Potentially inappropriate medications (PIMS) in older hospital in-patients: prevalence at admission and discharge, and contribution to hospital admission', Vol. 34, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354463000124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2014, 'Barriers to care in gout: A qualitative study of patients’ and prescribers’ understanding and management', Melbourne, Australia, presented at ASCEPT Scientific Meeting, Melbourne, Australia, 07 December 2014

Matthews GV; Kaur A; Ray JE; Graham GG; Egan B; Williams KM; Day RO, 2013, '870 USE OF A POPULATION PHARMACOKINETIC MODEL TO PREDICT WEEK 4 RIBAVIRIN LEVELS FROM EARLY CONCENTRATIONS', Vol. 58, pp. s357, http://dx.doi.org/10.1016/s0168-8278(13)60872-7

Day RO; Walker JS; Seideman P; Knihinicki RD; Williams K, 1990, 'A human model for evaluation of non-steroidal anti-inflammatory drug (NSAID) distribution into extracellular fluid', Vol. 183, pp. 1034, http://dx.doi.org/10.1016/0014-2999(90)92891-L

Walker JS; Day RO; Wessell H; Arroyo J, 1990, 'Validation of a human model of experimental pain for testing pharmacodynamics of non-steroidal anti-inflammatory drugs', Vol. 183, pp. 1036, http://dx.doi.org/10.1016/0014-2999(90)92893-N

Conference Presentations

Lin J; Pearson S; Greenfield J; Park KH; Havard A; Brieger D; Day R; Falster M, 2023, 'Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 analogues (GLP-1a) for cardiovascular risk in Australia (2014-2022)', presented at 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2023

Merriman T; Topless R; Day R; Kannangara D; Williams K; Bradbury L; Brown M; Harrison A; Hill C; Jones G; Lester S; Littlejohn G; Rischmueller M; Shenstone B; Smith M; Andres M; Bardin T; Doherty M; Janssen M; Jansen T; Joosten L; Perez-Ruiz F; Radstake T; Riches P; Roddy E; Tausche A-K; Stamp L; Dalbeth N; Liote F; So A; Rasheed H; Australasia OBOEAGII, 2014, 'THU0493 Association of the Toll-Like Receptor 4 (TLR4) Gene with Gout', http://dx.doi.org/10.1136/annrheumdis-2014-eular.4781

Lucas C; Ezard N; Day R, 2013, 'SYNTHETIC CANNABINOID USE: THE IMPORTANCE OF SURVEILLANCE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

CHAMPION GD; BIERI D; BROWNE CD; CAIRNS D; DAY RO; GRAHAM GG; HARRIS G; SAMBROOK PN, 1983, 'DETERMINATION OF RESPONSE OF INDIVIDUAL PATIENTS WITH RHEUMATOID-ARTHRITIS TO AURANOFIN', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

GRAHAM S; BROWNE CD; CHAMPION GD; DAY RO; SAMBROOK PN, 1982, 'CHLORAMBUCIL IN RHEUMATOID-ARTHRITIS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bieri D; Champion GD; Corrigan AB, 1977, 'Bioavailability, gastrointestinal microbleeding and side effects of four aspirin formulations in subjects with rheumatoid arthritis'

GRAHAM GG; CHAMPION GD; DAY RO, 1977, 'INFLUENCE OF CORTICOSTEROIDS ON METABOLISM AND PLASMA CONCENTRATIONS OF SALICYLATE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DH49400028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; CHAMPION GD; LITTOOY R; WADE DN, 1977, 'MAST-CELLS, INFLAMMATION AND ANTI-INFLAMMATORY DRUGS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DH49400019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

BIERI D; CHAMPION GD; DAY RO; GRAHAM GG; HASKI AL, 1977, 'MEASUREMENT OF SUBJECTIVE PARAMETERS OF RHEUMATOID-ARTHRITIS - DEVELOPMENT OF AN INDEX OF FUNCTION', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DH49400031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

HILLS LJ; BIERI D; CHAMPION GD; DAY RO; GRAHAM GG; HASKI A; PAULL PD, 1977, 'STATISTICAL PROCEDURES IN ANALYSIS OF AN ANALGESIC STUDY', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DS42200078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; RAY JE; CHAMPION GD; WADE DN, 1975, 'ACTION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON RAT MAST-CELLS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1975AU07300091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Champion GD; Day RO; Paull PD, 1975, 'Clinical pharmacology and efficacy of benorylate in patients with rheumatoid arthritis'

CHAMPION GD; DAY RO; PAULL PD; GRAHAM GG; OWEN MS; HASKI AL, 1975, 'CLINICAL PHARMACOLOGY AND EFFICACY OF BENORYLATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1975AU07300093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

GRAHAM G; CHAMPION GD; DAY RO; PAULL PD, 1975, 'PHARMACOKINETICS OF SALICYLATE IN SUBJECTS WITH RHEUMATOID-ARTHRITIS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1975AU07300090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Knock E; Ezard N; Day R; Siefried K; Liknaitzky P; Ross M; Albert S; Brett J, 2023, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: Recruitment to a novel safety and feasibility trial', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749

Asare-Doku W; Peprah P; Santo T; Weatherburn D, 2023, 'Global coverage and retention factors of criminal justice-related drug and alcohol treatment programs among offenders: A systematic review', in Global coverage and retention factors of criminal justice-related drug and alcohol treatment programs among offenders: A systematic review, presented at APSAD 2023 Conference, http://dx.doi.org/10.1111/dar.13749

Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'PRESCRIPTION OF SGLT2 INHIBITORS TO PATIENTS WITH CHRONIC KIDNEY DISEASE: A QUALITATIVE STUDY OF NEPHROLOGISTS AND CARDIOLOGISTS', in NEPHROLOGY, WILEY, Vol. 27, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000864433100145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Juhl CB; Simic M; Pihl K; Berthelsen DB; Day R; Koes B; Thorlund JB, 2022, 'COMPARISON OF EXERCISE THERAPY, NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, AND OPIOIDS FOR KNEE OSTEOARTHRITIS PAIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, GERMANY, Berlin, Vol. 30, pp. S65 - S66, presented at OARSI World Congress on Osteoarthritis, GERMANY, Berlin, 07 April 2022 - 10 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000775103700081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Knock E; Ezard N; Day R; Siefried KJ; Liknaitzky P; Ross M; Albert S; Brett J, 2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Green EAE; Yee SW; Rashkin SR; Witte J; Shin JG; Klovins J; Stocker S; Day R; Giacomini KM, 2019, 'GENETIC DETERMINANTS OF METFORMIN PHARM-ACOKINETICS: A METFORMIN GENETIC CONSORTIUM COLLABORATION.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, DC, Washington, Vol. 105, pp. S36 - S36, presented at Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, DC, Washington, 13 March 2019 - 16 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458561100109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shingde R; Graham G; Reuter S; Carland J; Williams K; Day R; Stocker S, 2019, 'PREDICTIVE PERFORMANCE OF A COMMERCIAL BAYESIAN FORECASTING PROGRAM IN ESTIMATING VANCOMYCIN DRUG EXPOSURE.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, DC, Washington, Vol. 105, pp. S38 - S38, presented at Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, DC, Washington, 13 March 2019 - 16 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458561100115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stocker SL; Carland JE; Moran MA; Tang S; Li CY; Alin JS; Gilbey T; Graham GG; Williams KM; Marriott DJ; Day RO, 2018, 'A CLINICAL EVALUATION OF VANCOMYCIN DOSING AND MONITORING.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, FL, Orlando, Vol. 103, pp. S88 - S88, presented at 119th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) - Breaking Down Barriers to Effective Patient Care, FL, Orlando, 21 March 2018 - 24 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424997100316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kamel B; Stocker S; Graham G; Carland J; Parker M; Williams K; Pile K; Portek I; McGill N; Day R, 2017, 'A MULTICENTRE OPEN-LABEL PHARMACOKINETIC-PHARMACODYNAMIC (PKPD) STUDY OF FEBUXOSTAT IN PATIENTS WITH CHRONIC GOUT', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 47, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400304400034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Simic M; Harmer AR; Agaliotis M; Nairn L; Bridgett L; March L; Votrubec M; Edmonds J; Norton R; Woodward M; Day R; Fransen M, 2016, 'Clinical predictors of medial knee osteoarthritis progression over 2 years', in Osteoarthritis and Cartilage, Elsevier BV, Vol. 24, pp. S220 - S220, http://dx.doi.org/10.1016/j.joca.2016.01.424

Leopoldino AO; Machado GC; Ferreira PH; Pinheiro MB; Day RO; McLachlan AJ; Hunter DJ; Ferreira ML, 2016, 'Efficacy and safety of paracetamol compared to placebo for knee and hip osteoarthritis: A cochrane systematic review', in Osteoarthritis and Cartilage, Elsevier, Vol. 24, pp. s44, http://dx.doi.org/10.1016/j.joca.2016.01.104

Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2015, 'IDENTIFYING BARRIERS TO TREATING GOUT EFFECTIVELY: A QUALITATIVE STUDY OF PATIENTS' AND GENERAL PRACTITIONERS' UNDERSTANDING AND MANAGEMENT OF GOUT', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen A; Baysari M; Kannangara D; Tariq A; Lau A; Westbrook J; Day R, 2015, 'MOBILE APPS TO ENHANCE SELF-MANAGEMENT OF GOUT: CONCORDANCE WITH MANAGEMENT GUIDELINES', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kannangara D; Day R; Williams K; Phipps-Green A; Dalbeth N; Stamp L; Merriman T, 2015, 'THE URATE TRANSPORTER ABCG2 AND THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU): CHANGING THE WAY WE THINK ABOUT HYPERURICAEMIA', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kannangara D; Graham G; Wright D; Barclay M; Stamp L; Williams K; Day R, 2015, 'TREATING GOUT PATIENTS WITH ALLOPURINOL: A CONCENTRATION- OR DOSE-RESPONSE APPROACH?', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 45, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fransen M; Agaliotis M; Nairn L; Votrubec M; Bridgett L; Su S; Jan S; March L; Edmonds J; Norton R; Woodward M; Day RO, 2014, 'Glucosamine and chondroitin for knee osteoarthritis: a double blind randomised controlled clinical trial evaluating single and combination regimens', in Osteoarthritis and Cartilage, Elsevier BV, Vol. 22, pp. S457 - S457, http://dx.doi.org/10.1016/j.joca.2014.02.868

Milder T; Lipworth W; Ritchie J; Williams K; Day R, 2011, 'WHAT DRIVES OSTEOARTHRITIS PATIENTS TO USE OR NOT USE NSAIDS, PARACETAMOL AND COMPLEMENTARY MEDICATIONS?', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 41, pp. 23 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Williams KM; March LM; Bertouch JV; Day RO, 2004, 'Subsided access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?', in Medical Journal of Australia, Australasian Med Publishing Company Ltd, Vol. 181, pp. 457 - 457

Williams KM; Cooper S; Parisis K; Handel M; Day RO, 2001, 'The skin suction blister: A human model of inflammation', in Clinical Pharmacology and Therapeutics, Vol. 69, pp. P61

Williams KM; Mclachlan AJ; Day RO; Pritchard A, 1998, 'Comparative pharmacokinetics of hepatitis B immuno-globulin after intramuscular administration in healthy subjects', in Naunyn - Schmiedebergs Archives of Pharmacology, Springer, New York, NY, USA, pp. 285, presented at Archives of Pharmacology 358, Munich, Germany

Day RO; Mclachlan AJ; Williams KM, 1998, 'Population pharmacokinetics (PK) and pharmacodynamics (PD) of tenoxicam (TN) in patients with rheumatoid arthritis (RA)', in Clinical Pharmacology and Therapeutics, Mosby, St Louis, MO, USA, pp. 168, presented at Clinical and Pharmacology Therapeutics

Williams KM; Turner J; Geisslinger G; Day RO, 1997, 'The suction blister as an in vivo model of inflammation: Interblister variability and preliminary studies of the disposition of methotrexate', in CLINICAL PHARMACOLOGY & THERAPEUTICS, MOSBY-YEAR BOOK INC, Vol. 61, pp. PI93 - PI93, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WJ68400093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; NGUYEN T; WILLIAMS KM, 1993, 'TENOXICAM DOSE CONCENTRATION RESPONSE RELATIONSHIP IN RHEUMATOID-ARTHRITIS (RA)', in CLINICAL PHARMACOLOGY & THERAPEUTICS, MOSBY-YEAR BOOK INC, Vol. 53, pp. 152 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KP26900067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Kumar SS; Graham GG; Smith FC; Furlong TJ; Greenfield JR; Stocker SS; Carland JE; Day RO, 2017, Could metformin be used in patients with advanced chronic kidney disease?, http://dx.doi.org/10.1111/dom.12806

Back to profile page